阿奇霉素静脉滴注联合康妇消炎栓治疗慢性附件炎效果观察

Effects of intravenous infusion of azithromycin combined with kangfu antiphlogistic suppository on patients with chronic adnexitis

目的探讨阿奇霉素静脉滴注联合康妇消炎栓治疗慢性附件炎的临床效果。方法回顾性分析2016年7月至2017年6月92例慢性附件炎患者的临床资料,按照随机数表法将其分为两组,每组46例。两组患者均给予阿奇霉素静脉滴注,观察组患者在此基础上加用康妇消炎栓直肠给药。比较两组患者停药1周、1个月后的临床治疗效果,记录两组不良反应及复发情况。结果停药1周后,观察组临床总有效率为95. 65%,高于对照组的80. 43%,差异有统计学意义(P <0. 05)。停药1个月后,观察组痊愈率为69. 57%,高于对照组的47. 83%,差异有统计学意义(P <0. 05)。两组患者在治疗过程中无明显不良反应,观察组复发率低于对照组,差异有统计学意义(P <0. 05)。结论阿奇霉素静脉滴注联合康妇消炎栓治疗慢性附件炎,可明显改善患者临床不良症状,降低复发率,治疗效果显著,建议临床推广应用。

Objective To investigate the clinical effects of intravenous infusion of azithromycin combined with kangfu antiphlogistic suppository on patients with chronic adnexitis. Methods The clinical data of 92 patients with chronic adnexitis from July 2016 to June 2017were retrospectively analyzed. They were divided into two groups according to the random number table method, with 46 cases in each group. The patients in both two groups were given intravenous infusion of azithromycin, and the patients in the observation group were given kangfu antiphlogistic suppository by rectal medication. The clinical effects of the two groups were compared after 1 week and 1 month of drug withdrawal, and the occurrence and recurrence of the two groups were recorded. Results After 1 week of drug withdrawal, the total effective rate of the observation group was 95.65%, which was higher than that of the control group （80.43%）, the difference was different （P 〈0. 05）. After 1 month of drug withdrawal, the cure rate of the observation group was 69. 57%, which was higher than that of the control group （47.83%）, and the difference was significant （P 〈 0. 05 ）. There were no significant in the adverse reactions between the two groups during the treatment. The recurrence rate in the observation group was lower than that in chronic adnexitis can obviously improve the clinical symptoms of the patients, reduce the recurrence rate, and the treatment effect is significant, which is worthv of clinical application.